IGF1 has been reported to amplify Fas antibody-induced apoptosis in human osteoblasts, to stimulate TNFα-induced apoptosis in murine myoblasts and preadipocytes, and to enhance Apo2L/TRAIL-induced apoptosis in human colon carcinoma cells [43, 45–47]. The gene discussed is FAS; the disease is colon carcinoma.